MC1297A1 - Composition aqueuse - Google Patents

Composition aqueuse

Info

Publication number
MC1297A1
MC1297A1 MC791415A MC1415A MC1297A1 MC 1297 A1 MC1297 A1 MC 1297A1 MC 791415 A MC791415 A MC 791415A MC 1415 A MC1415 A MC 1415A MC 1297 A1 MC1297 A1 MC 1297A1
Authority
MC
Monaco
Prior art keywords
water
soluble
pharmaceutical
pharmaceutical active
insoluble
Prior art date
Application number
MC791415A
Other languages
English (en)
French (fr)
Inventor
D Schmidt
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1297A1 publication Critical patent/MC1297A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MC791415A 1978-11-21 1979-11-15 Composition aqueuse MC1297A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1192178 1978-11-21

Publications (1)

Publication Number Publication Date
MC1297A1 true MC1297A1 (fr) 1980-10-03

Family

ID=4378189

Family Applications (1)

Application Number Title Priority Date Filing Date
MC791415A MC1297A1 (fr) 1978-11-21 1979-11-15 Composition aqueuse

Country Status (22)

Country Link
US (1) US4271196A (enExample)
EP (1) EP0011745B1 (enExample)
JP (1) JPS5572111A (enExample)
KR (1) KR850000584B1 (enExample)
AR (1) AR225294A1 (enExample)
AT (1) ATE501T1 (enExample)
AU (1) AU529061B2 (enExample)
CA (1) CA1136988A (enExample)
DE (1) DE2961718D1 (enExample)
DK (1) DK494079A (enExample)
ES (1) ES486157A0 (enExample)
FI (1) FI793461A7 (enExample)
GR (1) GR73668B (enExample)
HU (1) HU180792B (enExample)
IE (1) IE48659B1 (enExample)
IL (1) IL58723A (enExample)
MC (1) MC1297A1 (enExample)
NO (1) NO793759L (enExample)
NZ (1) NZ192118A (enExample)
PH (1) PH15561A (enExample)
PT (1) PT70478A (enExample)
ZA (1) ZA796116B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2952115C2 (de) * 1979-12-22 1982-05-06 A. Nattermann & Cie GmbH, 5000 Köln Rosmarinsäure-Phospholipid-Komplex
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
US4457918A (en) * 1982-05-12 1984-07-03 The General Hospital Corporation Glycosides of vitamins A, E and K
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
US4721612A (en) * 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes
US5231112A (en) 1984-04-12 1993-07-27 The Liposome Company, Inc. Compositions containing tris salt of cholesterol hemisuccinate and antifungal
US4891208A (en) * 1985-04-10 1990-01-02 The Liposome Company, Inc. Steroidal liposomes
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
IT1269569B (it) * 1994-04-22 1997-04-08 Ugo Citernesi Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
EP0682943B1 (de) * 1994-05-20 2003-08-20 GESELLSCHAFT FÜR MEDIZINISCHE FORSCHUNG UND WEITERBILDUNG e.V. GMF Lormetazepamhaltige Öl-in-Wasser-Emulsion
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
ES2306452T3 (es) * 1995-10-17 2008-11-01 Jagotec Ag Aporte de farmacos insolubles.
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
EP1054678B1 (en) * 1998-02-11 2003-05-28 RTP Pharma Corporation Combination of steroid and polyunsaturated fatty acids for treatment of inflammatory conditions
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
KR100635456B1 (ko) 1998-05-29 2006-10-18 스키에파마 캐나다 인코포레이티드 열보호화 마이크로입자 조성물 및 그의 말단의 스팀멸균방법
WO2000010531A1 (en) 1998-08-19 2000-03-02 Rtp Pharma Inc. Injectable aqueous dispersions of propofol
PL201578B1 (pl) 1998-11-20 2009-04-30 Skyepharma Canada Inc Stała terapeutyczna postać dawkowania nierozpuszczalnego lub słabo rozpuszczalnego w wodzie związku
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
DE60020382T2 (de) * 1999-09-21 2006-01-26 Skyepharma Canada Inc., Verdun Oberflächenmodifizierte teilchenförmige zusammensetzungen biologisch aktiver stoffe
NZ522239A (en) 2000-04-20 2004-03-26 Skyepharma Canada Inc Improved water-insoluble drug particle process
JP4969761B2 (ja) 2000-08-31 2012-07-04 オバン・エナジー・リミテッド 所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
WO2002024193A1 (en) * 2000-09-20 2002-03-28 Skyepharma Canada Inc. Stabilised fibrate microparticles
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
EP1361867B1 (en) * 2001-02-22 2007-03-21 Jagotec AG Fibrate-statin combinations with reduced fed-fasted effects
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU28584A1 (enExample) *
LU29060A1 (enExample) *
FR2102537A5 (enExample) * 1970-08-07 1972-04-07 Ugine Kuhlmann
FR2270887A1 (en) * 1974-05-16 1975-12-12 Chabrier De Lassauniere Pierre Prepn of lecithins and glycol-lecithins - by reaction of trimethylamine with 2-substd-2-oxo-1,3,2-dioxaphospholans
SE442014B (sv) * 1976-10-12 1985-11-25 Barry D Sears Syntetisk fosfatidyl-kvarter ammoniumforening till anvendning for solubilisering eller emulgering av vattenolosliga foreningar

Also Published As

Publication number Publication date
IL58723A (en) 1982-11-30
PH15561A (en) 1983-02-11
IL58723A0 (en) 1980-02-29
PT70478A (en) 1979-12-01
KR850000584B1 (ko) 1985-04-30
AU5282479A (en) 1980-05-29
ZA796116B (en) 1980-11-26
EP0011745B1 (de) 1981-12-30
AU529061B2 (en) 1983-05-26
ES8101855A1 (es) 1981-01-16
GR73668B (enExample) 1984-03-28
CA1136988A (en) 1982-12-07
HU180792B (en) 1983-04-29
DK494079A (da) 1980-05-22
NO793759L (no) 1980-05-22
NZ192118A (en) 1981-12-15
ATE501T1 (de) 1982-01-15
IE48659B1 (en) 1985-04-03
US4271196A (en) 1981-06-02
IE792216L (en) 1980-05-21
DE2961718D1 (en) 1982-02-18
EP0011745A1 (de) 1980-06-11
JPS5572111A (en) 1980-05-30
AR225294A1 (es) 1982-03-15
ES486157A0 (es) 1981-01-16
FI793461A7 (fi) 1981-01-01
JPH0122243B2 (enExample) 1989-04-25

Similar Documents

Publication Publication Date Title
MC1297A1 (fr) Composition aqueuse
JP3487860B2 (ja) 逆ミセル（ｌ２）構造または正常ミセル（ｌ１）構造を形成する制御放出組成物
CA2330500C (fr) Compositions pharmaceutiques gelifiables
FR2519864A1 (fr) Composition huileuse a base de medicaments antitumoraux
AU2013264466B2 (en) Improved complexes and compositions containing curcumin
HUP0301921A2 (hu) Elnyújtott hatóanyag-leadású készítmények hidrofil vegyületek parenterális adagolására
EP0004223A1 (fr) Procédé de fabrication de capsules lipidiques renfermant un matériau biologiquement actif, produits obtenus par ce procédé ainsi que leur utilisation
EP2644190A1 (fr) Formulation pour l'hormonothérapie
TW200817046A (en) An effective pharmaceutical carrier for poorly bioavailable drugs
WO1995028923A1 (fr) Compositions pharmaceutiques a base de derives de la classe des taxanes
CN1564796A (zh) 还原型辅酶q水溶液的稳定组合物
EP1014948B1 (fr) Composition pharmaceutique placebo lyophilisable destinee a imiter un medicament, notamment a base de proteines ou de polypeptides
EP1458413B1 (fr) Compositions pharmaceutiques a base de derives d azetidine
WO2009083664A1 (fr) Nouvelles compositions a base de taxoides
CN1168687A (zh) 抗氧化剂组合物
EP3432729A1 (fr) Nanocapsules de principe actif liposoluble, fabrication et utilisations
US20150110866A1 (en) Complexes and compositions containing curcumin
CA1275247C (fr) Procede de solubilisation, au moment de l'emploi, d'un principe actiflipophile dans une solution aqueuse, en vue de son administration par voie intraveineuse
FR2593394A1 (fr) Procede de preparation de liposomes contenant une subtance active lipophile, notamment de l'amphotericine, liposomes et nouveau medicament obtenus
CA2776198C (fr) Transport cooperatif de principes actifs basiques par des molecules amphiphiles acides
FR2635463A1 (fr) Composition pharmaceutique comportant un principe actif peu soluble dans l'eau et au moins un glyceride gelifie par au moins un polymere cellulosique
WO1990006106A1 (fr) Composition hydrophile d'un principe actif lipophile et liposome obtenu avec une telle composition
WO2006086864A1 (en) Pharmaceutical compositions comprising aromatic solubilizing agents
MC1181A1 (fr) Solutions injectables
MC2102A1 (fr) Application de micelles mixtes

Legal Events

Date Code Title Description
YP Annual fee paid